Cue Biopharma, Inc.CUENASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-1.09
↑ 86% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
-7.66
Historical baseline
PeriodValueYoY Change
2025-1.09+28.0%
2024-1.51+36.6%
2023-2.38-24.2%
2022-1.92+76.1%
2021-8.01+0.0%
2020-8.01+16.0%
2019-9.53-292.8%
2018-2.43+76.5%
2017-10.33+67.0%
2016-31.35-